The present study aims to address this gap by examining the longitudinal expression patterns of ABCC1, ABCB1, and ABCA2 in individuals with schizophrenia before and after antipsychotic treatment, and by comparing these patterns with those of healthy controls. The gene discussed is ABCC1; the disease is schizophrenia.